Vimarsana
Biggest News Aggregation in the World

Fda Reorganization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Reorganization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Reorganization Today - Breaking & Trending Today

Jones expects improved food oversight with FDA reorganization - Vimarsana News

Jones expects improved food oversight with FDA reorganization

While speaking on this week’s Agri-Pulse Newsmakers, Jim Jones, Food and Drug Administration deputy commissioner for Human Foods, says the infant formula crisis revealed the “structural flaw in the design” of leaders at FDA with competing decision-making authority that is now corrected under a proposed agency redesign.

Preventing foodborne illness, improving nutrition top priorities for new FDA food czar - Vimarsana News

Preventing foodborne illness, improving nutrition top priorities for new FDA food czar

FDA's newly minted deputy commissioner of foods, Jim Jones, says he's committed to implementing the recommendations of the Reagan-Udall Foundation report in a way that changes the agency's culture and oversight of human foods.

Former FDA official says FDA's reorganization won't solve issues | Agri-Pulse Communications, Inc. - Vimarsana News

Former FDA official says FDA's reorganization won't solve issues | Agri-Pulse Communications, Inc.

The infant formula crisis was a “preventable tragedy,” and the Food and Drug Administration’s proposed reorganizational changes fall short of the needed overhaul to improve FDA’s ability to prevent and respond to food safety concerns, Frank Yiannas, former FDA deputy commissioner in the Office of Food Policy and Response, detailed during a hearing before the House Oversight Committee.

Washington Week Ahead: Vilsack makes the rounds, FDA faces scrutiny - Vimarsana News

Washington Week Ahead: Vilsack makes the rounds, FDA faces scrutiny

Agriculture Secretary Tom Vilsack will testify before congressional committees over three straight days this week, and FDA Commissioner Robert Califf also will face lawmakers, who are certain to have questions about his ongoing reorganization of the agency’s human foods program.